Leshan market supervision department carried out training in the monitoring of adverse reactions in drug chemistry

Author:Municipal Supervision Observat Time:2022.07.08

In order to further strengthen the monitoring of the adverse reaction event of drug chemicalization, and comprehensively consolidate the main responsibility of the supervision of the adverse reaction incident of medical institutions, recently, the Leshan Market Supervision Department has successively organized a training meeting for the monitoring of drug abnormal reaction incidents in the area under its jurisdiction.

The Emeishan Market Supervision Bureau invited professionals from Leshan City Never Reaction Monitoring Center to give lectures to explain the basic knowledge, collection and reporting technical requirements, precautions, etc. of drugs, medical devices, and cosmetics adverse reactions. The demonstration and answered the questions encountered during the reporting process on the spot. After the meeting, the participants said that the training content was rich, targeted, full of dry goods, and abundant gains. It further expanded the professional knowledge. Provide data support to ensure the safety of people's use of medicinal equipment.

The county market supervision bureau, together with the health department, organized county -level medical institutions and town health centers to hold a standardized construction meeting of village -level medical institutions (toilets). At the meeting, the county was deployed in the monitoring of adverse reactions in medicine and medical device in 2022, and trained in the monitoring reporting work. The focus of explanation of the reports of adverse reactions in drugs and medical equipment over the years over the years Quality issues to ensure the monitoring and reporting quality and quantity of annual drugs and medical equipment adverse reactions.

The Market Supervision Bureau of Wutongqiao District jointly issued the "Notice on Doing the Monitoring of Pharmaceuticals, Medical Devices, Cosmetics for Pharmaceuticals, Cosmetics in 2022", and unlike the target plan to each monitoring unit. In the district's medical institution's adverse reaction monitoring work meeting, the reporting matters and key content of the adverse reaction monitoring were explained in detail, and in daily work, the daily contact mechanism of the monitoring unit was maintained through the "work group" to urge each monitoring unit to collect timely collection in time Reporting, communicating and guiding the difficult points in the monitoring work in time, improved the timelyness and effectiveness of the report.

The joint Health and Health Department of the Eibbian County Market Supervision Bureau held a monitoring and training meeting of 2022 drug medical device cosmetics adverse reactions, focusing on explaining how to monitor, how to report, and report the timeliness and precautions of the report of the adverse reaction incident of pharmaceutical chemicalization. The relevant provisions of the Drug Administration of the People's Republic of China on the monitoring of adverse drug reactions, and emphasized the newly added drug abuse monitoring work this year.

The monitoring of drug adverse reactions is the obligation and responsibility of drug listing permit holders, drug production, operating enterprises and medical institutions. Each monitoring unit shall raise awareness of monitoring, conduct monitoring in accordance with laws and regulations, and report in time, accurate, and real reports of adverse reactions reports. Focus on improving the quality of monitoring reports. (Yao Jia)

- END -

The new crown prevention and control plan has been adjusted!Three types of regions meet the standards to stop all -staff nucleic acid detection

Follow China Well -off .comOn June 28, the New Coronatte Pneumonic Pneumonia Preve...

Professor Zhang Xiaodong's list commented on Academician Jinming Two Sessions Proposal: It is recommended to include tumor screening into medical insurance

On July 1, the Top Ten Progress in the Cancer Field of the Public Public Most Incu...